TY  - JOUR
  - O'Brien, SM,Scott, LV,Dinan, TG
  - 2006
  - May
  - Rna-A Publication of The Rna Society
  - Antidepressant therapy and C-reactive protein levels
  - Validated
  - ()
  - CORONARY-ARTERY-DISEASE ACUTE-PHASE PROTEINS MAJOR DEPRESSION CARDIOVASCULAR-DISEASE INFLAMMATION MARKERS PREDICTION ACTIVATION
  - 188
  - 449
  - 452
  - Background Major depression is associated with activation of the inflammatory response.Aims To examine C-reactive protein levels in depression and to determine the impact of selective serotonin reuptake inhibitor (SSRI) therapy.Method A two-part study In study 1, which used a between -subjects design, C-reactive protein was measured in 32 patients (20 currently depressed, 12 euthymic) with a history of DSM - IV major depression, all of whom were treated with an SSRI, and in a healthy comparison group (n=20). Study 2 employed a within-subject design: C-reactive protein was measured in 20 patients with major depression both before and after SSRI treatment.Results In study 1, C- reactive protein levels did not differ between the group with depressive disorder (either currently depressed or euthymic) treated with SSRIs and the healthy group. In study 2 the protein levels dropped significantly following treatment with antidepressant medication.Conclusions Following SSRI treatment for major depression there is a significant drop in C-reactive protein concentrations whether or not the depression resolves. These findings indicate that antidepressants induce an anti -inflammatory response independent of antidepressant action.Declaration of interest T.G.D. has lectured at meetings sponsored by or acted as an advisor to all companies who market a branded SSRI.
DA  - 2006/05
ER  - 

@article{V43336819,
   = {O'Brien,  SM and Scott,  LV and Dinan,  TG },
   = {2006},
   = {May},
   = {Rna-A Publication of The Rna Society},
   = {Antidepressant therapy and C-reactive protein levels},
   = {Validated},
   = {()},
   = {CORONARY-ARTERY-DISEASE ACUTE-PHASE PROTEINS MAJOR DEPRESSION CARDIOVASCULAR-DISEASE INFLAMMATION MARKERS PREDICTION ACTIVATION},
   = {188},
  pages = {449--452},
   = {{Background Major depression is associated with activation of the inflammatory response.Aims To examine C-reactive protein levels in depression and to determine the impact of selective serotonin reuptake inhibitor (SSRI) therapy.Method A two-part study In study 1, which used a between -subjects design, C-reactive protein was measured in 32 patients (20 currently depressed, 12 euthymic) with a history of DSM - IV major depression, all of whom were treated with an SSRI, and in a healthy comparison group (n=20). Study 2 employed a within-subject design: C-reactive protein was measured in 20 patients with major depression both before and after SSRI treatment.Results In study 1, C- reactive protein levels did not differ between the group with depressive disorder (either currently depressed or euthymic) treated with SSRIs and the healthy group. In study 2 the protein levels dropped significantly following treatment with antidepressant medication.Conclusions Following SSRI treatment for major depression there is a significant drop in C-reactive protein concentrations whether or not the depression resolves. These findings indicate that antidepressants induce an anti -inflammatory response independent of antidepressant action.Declaration of interest T.G.D. has lectured at meetings sponsored by or acted as an advisor to all companies who market a branded SSRI.}},
  source = {IRIS}
}